Article information
Resumen
Nos encontramos ante el caso de una paciente embarazada con un brote agudo de su enfermedad de Crohn sin seguimiento de su tratamiento que,aun comenzando con un estado quiescente,se ve afectada por un cuadro agudo de microperforación ileal.
Abstract
We were presented with the case of a pregnant patient with a recurrence of her Crohn’s disease.She was receiving no treatment, which began gently but ended acutely with an ileal micro-perforation.
Full text is only aviable in PDF
Bibliografía
[1.]
JP. Millar.
Inflammatory bowel disease in pregnancy. A review.
J Roy Soc Med, 79 (1986), pp. 221
[2.]
EM Alstead, Piercy C. Nelson.
Inflammatory bowel disease in pregnancy.
Gut, 52 (2003), pp. 1070
[3.]
L Iffy, Harold A. Kaminetzky.
Obstetricia y perinatología. Trastornos gastrointestinales y embarazo. ED Med Panamericana S.A.
pp. 1335-1336
[4.]
EM Alstead, Piercy C. Nelson.
Inflammartory bowel disease in pregnancy.
Gut, 52 (2003), pp. 243-247
[5.]
N. Gleicher.
Medicina clínica en obstetricia. edfermedad intestinal inflamatoria. ed Med Panamericana.
pp. 941-943
[6.]
Obstetrician. Willians.
Complicaciones Médicas y Quirúrgicas durante el Embarazo. Enfermedades gastrointestinales.
21.a, pp. 1081-1084
[7.]
K Woolfson, Z Cohen, RS. McLeod.
Crohn’s diseadise in pregnancy.
Dis Colon Rectum, 33 (1990), pp. 869
[8.]
L atznelson, WP Fairfield, N Zeizafoun, BE Sands, MA Peppercorn, DI Rosenthal, et al.
Effects of growth hormone secretion on body composition in patients with Crohn’s disease.
J Clin Endocrinol Metab, 88 (2003), pp. 5468-5472
[9.]
D Kornfeld, S Cnattingius, A. Elkbon.
Pregnancy outcomes in women with inflamatory bowel disease.
Obstet Gynecol, 177 (1997), pp. 942
[10.]
K Fonager, HT Sorensen, J. Olsen.
Pregnancy outcome for women with crohn disease.
Am J Gastroenterol, 93 (1998), pp. 2426
[11.]
Earle C Sola, F Nogueras, M. Rodrigo.
Tratamiento de la enfermedad inflamatoria intestinal.
Pat Digest, 18 (1995), pp. 9-12
[12.]
GS Tay, DG Binion, D Eastwood, MF. Otterson.
Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and or strictureplasty.
Surgery, 134 (2003), pp. 565-572
[13.]
MA. Peppercorn.
Advances in drug therapy for inflammatory bowel disease.
Ann Intern Med, 112 (1990), pp. 50-60
[14.]
MJ. Sprint.
Antibiotics in inflammatory bowel disease: new choices for an old disease.
Am J Gastroenterol, 89 (1994), pp. 974-978
[15.]
GF Swift, ED Erivastava, R Stone, RD Pullan, RG Newcombe, J Rhodes, et al.
Controlled trial of antituberculous chemotherapy for two years in Crohn’s disease.
Gut, 35 (1994), pp. 363-368
[16.]
C Prantera, A Kohn, R Mangiarotti, A Andreoli, C. Luzi.
Antimycobacterial therapy in Crohn’s disease: results of a controlled, double blind trial with a multiple antibiotic regimen.
Am J Gastroenterol, 89 (1994), pp. 513-518
[17.]
J. Schoetz-David.
Anal Fistulas: treatment options in the new millennium. Seminars in Colon & Rectal.
Surgery, 14 (2003), pp. 100-105
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
